QURE
Uniqure NV
NASDAQ: QURE · HEALTHCARE · BIOTECHNOLOGY
$16.73
-7.31% today
Updated 2026-04-29
Market cap
$1.05B
P/E ratio
—
P/S ratio
65.51x
EPS (TTM)
$-3.46
Dividend yield
—
52W range
$9 – $72
Volume
3.4M
Uniqure NV (QURE) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+9.3%
Last 4 quarters
Revenue YoY growth
+6.6%
Most recent quarter
EPS YoY growth
+67.1%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-11.6%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-42.2%
2026-03-02
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-02 | $-0.47 | +48.3% | $15.63 | $9.03 | -42.2% |
| 2025-11-10 | $-1.38 | -51.6% | $27.79 | $30.84 | +11.0% |
| 2025-07-29 | $-0.69 | +22.5% | $14.98 | $14.46 | -3.5% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.92 | $-0.47 | +48.3% | $5.57M | +6.6% |
| 2025-09-30 | $-0.91 | $-1.38 | -51.6% | $3.70M | +61.8% |
| 2025-06-30 | $-0.89 | $-0.69 | +22.5% | $5.26M | -52.7% |
| 2025-03-31 | $-0.89 | $-0.73 | +17.9% | $1.57M | -81.5% |
| 2024-12-31 | $-0.52 | $-1.44 | -178.8% | $5.22M | -21.9% |
| 2024-09-30 | $-1.02 | $-0.91 | +10.8% | $2.29M | +62.5% |
| 2024-06-30 | $-1.25 | $-1.16 | +7.2% | $11.13M | +359.4% |
| 2024-03-31 | $-1.28 | $-1.36 | -6.3% | $8.48M | — |
| 2023-12-31 | $-1.46 | $-1.53 | -4.8% | $6.69M | — |
| 2023-09-30 | $-0.85 | $-1.88 | -121.2% | $1.41M | — |
| 2023-06-30 | $2.05 | $-1.44 | -170.2% | $2.42M | — |
Frequently asked questions
Has Uniqure NV beaten earnings estimates?
Uniqure NV has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +9.3% over the last 4 quarters.
How does QURE stock react to earnings?
QURE stock has moved an average of -11.6% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is Uniqure NV's revenue growth rate?
Uniqure NV reported year-over-year revenue growth of +6.6% in its most recent quarter, with EPS growing +67.1% year-over-year.